SpringerLink
Log in

Die CABANA-Studie und ihre Folgen: Aktuelle Evidenzlage zur Katheterablation von Vorhofflimmern

The CABANA trial and its impact on clinical routine: current evidence of catheter ablation of atrial fibrillation

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Andersson T, Magnuson A, Bryngelsson IL, Frøbert O, Henriksson KM, Edvardsson N, Poçi D (2013) All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995–2008: A Swedish nationwide long-term case-control study. Eur Heart J 34:1061–1067

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hsu LF, Jaïs P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquié JL, Scavée C, Bordachar P, Clémenty J, Haïssaguerre M (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383

    Article  CAS  PubMed  Google Scholar 

  3. Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, Sugumar H, Lockwood SM, Stokes MB, Pathik B, Nalliah CJ, Wong GR, Azzopardi SM, Gutman SJ, Lee G, Layland J, Mariani JA, Ling LH, Kalman JM, Kistler PM (2017) Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: The CAMERA-MRI study. J Am Coll Cardiol 70:1949–1961

    Article  PubMed  Google Scholar 

  4. Freudenberger RS, Wilson AC, Kostis JB, AFFIRM Investigators and Committees (2007) Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study). Am J Cardiol 100:247–252

    Article  PubMed  Google Scholar 

  5. Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: Results from the AATAC multicenter randomized trial. Circulation 133:1637–1644

    Article  CAS  PubMed  Google Scholar 

  6. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D (2018) Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378:417–427

    Article  PubMed  Google Scholar 

  7. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL (2019) Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: The CABANA randomized clinical trial. JAMA. https://doi.org/10.1001/jama.2019.0693

    Article  PubMed  PubMed Central  Google Scholar 

  8. Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, Daniels MR, Bahnson TD, Poole JE, Rosenberg Y, Lee KL, Packer DL (2019) Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: The CABANA randomized clinical trial. JAMA. https://doi.org/10.1001/jama.2019.0692

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Kardiologie II/interventionelle Elektrophysiologie, RHÖN-KLINIKUM Campus Bad Neustadt, Von-Guttenberg-Straße 11, 97616, Bad Neustadt/Saale, Deutschland

    P. Halbfass &  T. Deneke

Authors
  1. P. Halbfass
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Deneke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Halbfass.

Ethics declarations

Interessenkonflikt

P. Halbfass und T. Deneke geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Halbfass, P., Deneke, T. Die CABANA-Studie und ihre Folgen: Aktuelle Evidenzlage zur Katheterablation von Vorhofflimmern. Kardiologe 13, 258–263 (2019). https://doi.org/10.1007/s12181-019-00345-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-019-00345-4

Search

Navigation